News & updates

From elsewhere: A new technique for detecting disease biomarkers


Tests to diagnose Alzheimer's disease and cancer at the molecular level are being developed by scientists at the National Physical Laboratory (NPL) in London, who have developed a faster and more precise process to detect proteins associated with disease a new paper reveals.

Identifying disease-related proteins - known as biomarkers - in body fluid such as blood can be a useful medical tool. Much work is being done into discovering prognostic and diagnostic biomarkers for use in targeted treatments.

For the full article, by Harriet Vickers in BioNews 574, please click here.


FP7 & EU flag